Today, September 1st, India will receive its first cervical cancer vaccine, Quadrivalent Human Papillomavirus vaccine (qHPV). Jitendra Singh, Union Minister of State (Independent Charge) Science and Technology, will announce the much-anticipated vaccination at IIC Delhi. On July 12, the Drugs Controller General of India (DCGI) awarded Serum Institute of India (SII) market authorization to manufacture an indigenously designed vaccine against cervical cancer. Cervical cancer is the second most common malignancy among women between the ages of 15 and 44 in India. The breakthrough step for Indian demography will now aid in the prevention of cervical cancer instances. According to Dr
The Centre on Thursday announced the "Cervavac", India's first indigenously-developed vaccine for prevention of cervical cancer, will be launched in the next few months and will be available in the price range of Rs 200-Rs .